We have reported that EVA1A is a potential tumor suppressor gene for HCC and that its downregulation is associated with poor clinical outcomes for HCC patients [10], so we evaluated the effect of EVA1A on the malignant action of miR-103a-3p in HCC. The gene discussed is EVA1A; the disease is hepatocellular carcinoma.